Several chronic and acute health conditions now use wearable devices as part of standard medical care, from continuous glucose monitors for diabetes to wrist-worn seizure detectors for epilepsy. These aren’t fitness trackers. They’re medical-grade tools that collect data your doctor uses to adjust treatment, catch dangerous changes early, or prevent hospital readmissions. Medicare covers remote monitoring for any chronic or acute condition that requires it, as long as the device meets FDA standards and transmits data at least 16 days out of every 30.
Diabetes
Continuous glucose monitors (CGMs) are the most widely prescribed wearable medical devices. A small sensor inserted just under the skin reads glucose levels every few minutes and sends the data to a phone or receiver, replacing most fingerstick blood tests. The American Diabetes Association recommends CGMs for anyone on intensive insulin therapy, whether they have type 1 or type 2 diabetes, particularly those using multiple daily injections or an insulin pump.
Insurance coverage, however, doesn’t always match clinical recommendations. Medicare covers CGMs for both type 1 and intensively treated type 2 diabetes, but many state Medicaid programs limit coverage to type 1 only. Thirteen state programs also require documented proof that you’ve been testing your blood sugar with fingersticks at least four times a day before they’ll approve a CGM. Several major private insurers have similar restrictions, and some don’t cover CGMs for type 2 diabetes at all. If you use insulin and struggle with blood sugar swings, hypoglycemia unawareness, or difficulty hitting your glucose targets, a CGM is the primary wearable your care team will consider.
Epilepsy and Seizure Disorders
Two FDA-cleared wearable devices exist specifically for detecting convulsive seizures. The Empatica Embrace, a wrist-worn smartwatch cleared in 2018, uses motion sensing and skin conductance to identify seizure-like movements, then sends an alert to a caregiver’s phone through a paired app. The second, BrainSentinel SPEAC, attaches to the upper arm with an adhesive patch and detects the muscle activity patterns of a convulsion. It was FDA-cleared in 2017.
Both devices are most reliable for tonic-clonic (grand mal) seizures, which involve full-body convulsions. Detecting other seizure types, like absence seizures or focal seizures without obvious movement, remains much harder for wearable sensors. For people who live alone or whose seizures happen during sleep, these devices fill a critical safety gap by making sure someone is notified quickly.
Heart Failure
Heart failure is one of the leading causes of hospital readmission, and remote monitoring aims to catch warning signs of fluid overload before they become emergencies. Typical monitoring kits sent home with patients include a blood pressure cuff, a pulse oximeter, and a digital scale, all connected to a tablet that transmits readings to a care team. Weight gain is one of the strongest predictors of readmission because it signals fluid retention, while drops in systolic blood pressure are more closely linked to mortality risk.
When clinicians see concerning trends in this data, they can intervene early. That might mean adjusting diuretic doses over the phone or scheduling a same-day infusion clinic visit to remove excess fluid intravenously, rather than waiting until the patient shows up in the emergency room unable to breathe.
Atrial Fibrillation and Heart Rhythm Disorders
Atrial fibrillation (AFib) is the arrhythmia most commonly tracked with wearable ECG devices, including consumer products like the Apple Watch and dedicated medical monitors. These devices take a single-lead ECG recording from your wrist or fingertips and flag irregular rhythms. For people with intermittent AFib, which may come and go unpredictably, wearables can capture episodes that a standard office ECG would miss entirely.
There are real limitations, though. Most wearable algorithms only distinguish between AFib and normal sinus rhythm. They frequently produce false positives when other rhythm irregularities are present, like atrial flutter or frequent premature beats. Any wearable reading still needs to be confirmed by a physician, typically through extended monitoring with a Holter monitor or loop recorder. Wearable ECGs are best understood as a screening and alerting tool, not a diagnostic replacement.
Parkinson’s Disease
Wearable sensors are increasingly used to give neurologists an objective, continuous picture of Parkinson’s motor symptoms between office visits. Several commercial devices track the three hallmark movement problems. For tremor, sensors analyze specific low-frequency motion patterns from an accelerometer worn on the wrist. Bradykinesia, the characteristic slowness of movement, is scored by measuring maximum acceleration and movement frequency, then correlating those numbers with standard clinical rating scales. Gait problems, including freezing of gait (where a person suddenly feels stuck mid-step), are detected by devices worn on the body that use machine learning to classify walking patterns.
This data helps neurologists fine-tune medication timing and dosing. Parkinson’s symptoms fluctuate throughout the day as medication levels rise and fall, and a wearable diary captures those fluctuations far more accurately than a patient’s self-report or a brief clinic appointment.
Asthma and Chronic Respiratory Conditions
For asthma and COPD, the two vital signs most useful for wearable tracking are breathing rate and airflow sounds. A healthy adult breathes 12 to 20 times per minute at rest. During an asthma exacerbation, that rate can climb above 30 breaths per minute. Wearable sensors can measure this directly through chest movement or estimate it indirectly from heart rate patterns.
Wheezing detection is the other key capability. Wheezing is the high-pitched whistling sound produced when airways narrow from inflammation or spasm. Chest-worn sensors can record breathing sounds and process them to identify wheezing patterns. The Omron WheezeScan is one commercially available, clinically approved device designed for this purpose. Catching early wheezing or a rising breathing rate can signal an exacerbation hours before it becomes severe, giving you time to use a rescue inhaler or adjust your controller medication.
Post-Surgical Recovery
After major surgery, wearable devices are used to track recovery both in the hospital and after discharge. The most common metric is step count: nearly all studies on post-surgical wearables use accelerometers or pedometers to measure physical activity. Other tracked data includes distance walked, walking speed, sleep duration, nighttime awakenings, and in some cases body temperature and heart rhythm.
These numbers turn out to be surprisingly predictive. Research on cancer surgery patients found that Fitbit step counts during the hospital stay predicted who would be readmitted. Similar findings emerged after cardiac surgery, where in-patient step counts predicted re-hospitalization. The logic is straightforward: patients who are moving less than expected may be developing complications like infection, blood clots, or organ dysfunction before those problems show up on a lab test. Some specialized post-surgical wearables go further, using light-based sensors to measure tissue oxygen levels in skin flaps or grafts to make sure transplanted tissue is getting adequate blood flow.
How Insurance Covers These Devices
Medicare reimburses remote physiologic monitoring as three separate components: setting up the device, collecting and transmitting data, and clinical review of that data. To qualify, you need a chronic or acute condition that requires monitoring, and the device must be FDA-recognized and upload data digitally for at least 16 out of every 30 days. The reimbursement rate is the same regardless of which device you use or what health data it collects.
Private insurance coverage varies significantly by carrier and plan. Some conditions, like insulin-treated diabetes, have relatively well-established coverage pathways, while others, like Parkinson’s motor tracking, may require prior authorization or fall outside standard coverage. Your prescribing physician’s office typically handles the insurance approval process, but it helps to know upfront whether your specific insurer covers the device and what documentation they require.